AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home iLIVER Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Navigating the future of liver disease research: A roadmap for iLIVER

Lei Caia, Ming-Da Wangb, Tian Yangb( )
Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing 401147, China
Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University, Shanghai 200438, China
Show Author Information

Keywords

Artificial intelligenceLiver cancerHepatocellular carcinomaLiver diseaseNon-alcoholic fatty liver disease

References

[1]

Younossi ZM, Golabi P, Paik JM, et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 2023;77(4):1335–47. https://doi.org/10.1097/HEP.0000000000000004.
Crossref Google Scholar
[2]

Bhattacharya D, Aronsohn A, Price J, et al. Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin Infect Dis 2023:ciad319. https://doi.org/10.1093/cid/ciad319.
Crossref Google Scholar
[3]

Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma. Lancet 2022;400(10360):1345–62. https://doi.org/10.1016/S0140-6736(22)01200-4.
Crossref Google Scholar
[4]

Wang MD, Diao YK, Yao LQ, et al. Emerging role of molecular diagnosis and personalized therapy for hepatocellular carcinoma. iLIVER 2024;3(1). https://doi.org/10.1016/j.iliver.2024.100083.
Crossref Google Scholar
[5]

Nagino M. Perihilar cholangiocarcinoma: a surgeon's perspective. iLIVER 2022;1(1):12–24. https://doi.org/10.1016/j.iliver.2022.03.004.
Crossref Google Scholar
[6]

Sousa Da Silva RX, Muellhaupt B, Dutkowski P, et al. Liver transplantation for malignant liver tumors. iLIVER 2022;1(1):3–11. https://doi.org/10.1016/j.iliver.2022.04.002.
Crossref Google Scholar
iLIVER
Volume 3 Issue 1,
March 2024
DOI: 10.1016/j.iliver.2024.100084
Cite this article:
Cai L, Wang M-D, Yang T. Navigating the future of liver disease research: A roadmap for iLIVER. iLIVER, 2024, 3(1). https://doi.org/10.1016/j.iliver.2024.100084

175

Views

0

Crossref

Altmetrics
Received: 18 February 2024
Accepted: 21 February 2024
Published: 27 February 2024
© 2024 The Authors. Tsinghua University Press.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return